Royce & Associates LP Has $9.99 Million Holdings in Stevanato Group S.p.A. (NYSE:STVN)

Royce & Associates LP lifted its stake in shares of Stevanato Group S.p.A. (NYSE:STVN) by 33.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 458,335 shares of the company’s stock after purchasing an additional 115,176 shares during the period. Royce & Associates LP owned approximately 0.15% of Stevanato Group worth $9,987,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Conestoga Capital Advisors LLC lifted its holdings in Stevanato Group by 5.3% during the 4th quarter. Conestoga Capital Advisors LLC now owns 8,082,996 shares of the company’s stock worth $176,128,000 after buying an additional 407,086 shares in the last quarter. TimesSquare Capital Management LLC lifted its stake in shares of Stevanato Group by 114.6% during the fourth quarter. TimesSquare Capital Management LLC now owns 3,288,529 shares of the company’s stock valued at $71,657,000 after acquiring an additional 1,756,100 shares during the period. Thrivent Financial for Lutherans boosted its holdings in Stevanato Group by 67.6% in the third quarter. Thrivent Financial for Lutherans now owns 2,784,912 shares of the company’s stock valued at $55,698,000 after acquiring an additional 1,123,104 shares during the last quarter. Wellington Management Group LLP increased its position in Stevanato Group by 4.5% in the third quarter. Wellington Management Group LLP now owns 2,693,588 shares of the company’s stock worth $53,872,000 after purchasing an additional 115,050 shares during the period. Finally, Bamco Inc. NY raised its holdings in Stevanato Group by 1.3% during the 3rd quarter. Bamco Inc. NY now owns 1,685,181 shares of the company’s stock worth $33,704,000 after purchasing an additional 21,469 shares during the last quarter.

Analysts Set New Price Targets

Several brokerages have recently commented on STVN. Morgan Stanley reiterated an “equal weight” rating and set a $23.00 price target (down previously from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. William Blair reaffirmed an “outperform” rating on shares of Stevanato Group in a report on Friday, March 7th. UBS Group cut their price target on Stevanato Group from $24.00 to $23.50 and set a “neutral” rating on the stock in a research note on Friday, March 7th. Wolfe Research began coverage on Stevanato Group in a research note on Friday, December 13th. They set an “outperform” rating and a $28.00 price objective for the company. Finally, Bank of America raised their target price on Stevanato Group from $24.00 to $26.00 and gave the stock a “buy” rating in a report on Friday, December 13th. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, Stevanato Group presently has an average rating of “Moderate Buy” and a consensus price target of €27.75 ($30.16).

Stevanato Group Stock Up 3.4 %

NYSE:STVN opened at €20.71 ($22.51) on Tuesday. Stevanato Group S.p.A. has a 1 year low of €16.56 ($18.00) and a 1 year high of €33.49 ($36.40). The stock has a 50-day moving average price of €21.16 and a two-hundred day moving average price of €20.58. The stock has a market cap of $6.27 billion, a price-to-earnings ratio of 44.06, a PEG ratio of 7.18 and a beta of 0.60. The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22.

Stevanato Group (NYSE:STVN) last posted its earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of €0.20 ($0.22). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The business had revenue of €352.68 million during the quarter, compared to analysts’ expectations of €346.26 million. As a group, equities analysts expect that Stevanato Group S.p.A. will post 0.5 earnings per share for the current year.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.